Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$6,713,210
+$1,615,845 QoQ
Shares Held
5,597
+1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#1,503
of 4,604 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AZZAD ASSET MANAGEMENT INC /ADV holds $52,280,324 across 9 Drug Manufacturers - General names. LLY ranks #3 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
87,982 | $11,305,687 | |
| 2 | ABBV |
AbbVie Inc.
|
31,610 | $7,954,340 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
5,597 | $6,713,210 | |
| 4 | AZN |
Astrazeneca PLC
|
32,868 | $6,232,430 | |
| 5 | JNJ |
Johnson & Johnson
|
24,292 | $6,169,439 | |
| 6 | NVO |
Novo Nordisk A S
|
107,307 | $5,144,297 | |
| 7 | NVS |
Novartis AG
|
30,427 | $4,768,519 | |
| 8 | AMGN |
Amgen Inc
|
9,364 | $3,390,891 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,713,210 | 5,597 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $5,097,365 | 5,542 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,044,000 | 5,624 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $4,381,909 | 5,743 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,705,885 | 4,754 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,909,032 | 4,733 | Shares | Sole | 2025-04-16 | |
| 2024-09-30 | $1,710,750 | 1,931 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $1,570,834 | 1,735 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,411,219 | 1,814 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,031,185 | 1,769 | Shares | Sole | 2024-04-01 | |
| 2023-09-30 | $615,550 | 1,146 | Shares | Sole | 2024-04-01 | |
| 2023-06-30 | $487,739 | 1,040 | Shares | Sole | 2024-04-01 | |
| 2023-03-31 | $408,326 | 1,189 | Shares | Sole | 2024-04-01 | |
| 2022-12-31 | $459,495 | 1,256 | Shares | Sole | 2024-04-01 | |
| 2022-09-30 | $3,884,403 | 12,013 | Shares | Sole | 2024-04-01 | |
| 2022-06-30 | $4,982,766 | 15,368 | Shares | Sole | 2024-04-01 | |
| 2022-03-31 | $1,170,966 | 4,089 | Shares | Sole | 2024-04-01 | |
| 2021-12-31 | $952,682 | 3,449 | Shares | Sole | 2024-04-01 | |
| 2021-09-30 | $827,852 | 3,583 | Shares | Sole | 2024-04-01 | |
| 2021-06-30 | $785,187 | 3,421 | Shares | Sole | 2024-04-01 | |
| 2021-03-31 | $643,594 | 3,445 | Shares | Sole | 2024-04-01 | |
| 2020-12-31 | $2,093,447 | 12,399 | Shares | Sole | 2024-04-01 | |
| 2020-09-30 | $1,815,613 | 12,266 | Shares | Sole | 2024-04-01 | |
| 2020-06-30 | $1,768,546 | 10,772 | Shares | Sole | 2024-04-01 | |
| 2020-03-31 | $1,672,824 | 12,059 | Shares | Sole | 2024-04-01 | |
| No filing history on record for this holder in this stock. | ||||||